Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chagas Disease | 6 | 2022 | 101 | 2.530 |
Why?
|
| Trypanosoma cruzi | 5 | 2022 | 154 | 1.950 |
Why?
|
| Glycoproteins | 7 | 2023 | 127 | 1.790 |
Why?
|
| Leishmaniasis, Cutaneous | 4 | 2023 | 18 | 1.310 |
Why?
|
| Polysaccharides | 3 | 2022 | 70 | 1.170 |
Why?
|
| Leishmania braziliensis | 2 | 2023 | 4 | 1.050 |
Why?
|
| Epitopes | 6 | 2018 | 155 | 0.750 |
Why?
|
| Peptides | 2 | 2018 | 357 | 0.660 |
Why?
|
| Glycosides | 2 | 2012 | 22 | 0.600 |
Why?
|
| Biomimetic Materials | 1 | 2018 | 24 | 0.560 |
Why?
|
| Protozoan Proteins | 2 | 2019 | 196 | 0.550 |
Why?
|
| Protozoan Vaccines | 1 | 2015 | 16 | 0.480 |
Why?
|
| Oligosaccharides | 1 | 2015 | 28 | 0.470 |
Why?
|
| Glycomics | 2 | 2012 | 8 | 0.450 |
Why?
|
| Galactose | 1 | 2013 | 9 | 0.420 |
Why?
|
| Glycoconjugates | 2 | 2011 | 6 | 0.420 |
Why?
|
| Trisaccharides | 2 | 2023 | 11 | 0.410 |
Why?
|
| Acetates | 1 | 2012 | 29 | 0.370 |
Why?
|
| Adaptive Immunity | 1 | 2011 | 32 | 0.350 |
Why?
|
| Antigens, Surface | 1 | 2011 | 50 | 0.350 |
Why?
|
| Glycopeptides | 2 | 2012 | 14 | 0.340 |
Why?
|
| Amino Acids | 3 | 2007 | 150 | 0.330 |
Why?
|
| Mucins | 2 | 2022 | 69 | 0.330 |
Why?
|
| Carbohydrate Conformation | 3 | 2013 | 15 | 0.260 |
Why?
|
| Sulfhydryl Compounds | 1 | 2007 | 49 | 0.260 |
Why?
|
| Glucosides | 1 | 2005 | 21 | 0.230 |
Why?
|
| Humans | 13 | 2023 | 42163 | 0.220 |
Why?
|
| Mannose | 1 | 2023 | 30 | 0.210 |
Why?
|
| Mass Spectrometry | 2 | 2016 | 279 | 0.190 |
Why?
|
| Ultraviolet Rays | 2 | 2018 | 118 | 0.190 |
Why?
|
| Indoles | 2 | 2018 | 178 | 0.180 |
Why?
|
| Signal Transduction | 1 | 2011 | 2111 | 0.180 |
Why?
|
| Leishmania major | 2 | 2018 | 23 | 0.170 |
Why?
|
| Neoplasms | 1 | 2011 | 1341 | 0.160 |
Why?
|
| Glycosylation | 2 | 2012 | 111 | 0.150 |
Why?
|
| Chronic Disease | 1 | 2022 | 541 | 0.140 |
Why?
|
| Antibodies, Helminth | 1 | 2018 | 24 | 0.140 |
Why?
|
| Antigens, Helminth | 1 | 2018 | 34 | 0.140 |
Why?
|
| Leishmaniasis Vaccines | 1 | 2017 | 8 | 0.140 |
Why?
|
| Galactosides | 1 | 2017 | 11 | 0.140 |
Why?
|
| Fluorescence | 1 | 2018 | 113 | 0.140 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2018 | 72 | 0.130 |
Why?
|
| Collagen | 1 | 2018 | 178 | 0.130 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 2016 | 11 | 0.130 |
Why?
|
| Photochemistry | 2 | 2007 | 58 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2019 | 456 | 0.130 |
Why?
|
| Fibroblasts | 1 | 2018 | 278 | 0.120 |
Why?
|
| Peptide Fragments | 1 | 2018 | 301 | 0.120 |
Why?
|
| Acylation | 2 | 2006 | 11 | 0.120 |
Why?
|
| Metals | 1 | 2016 | 113 | 0.120 |
Why?
|
| Aspartic Acid | 2 | 2006 | 51 | 0.120 |
Why?
|
| Antibodies, Protozoan | 1 | 2015 | 82 | 0.110 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2006 | 300 | 0.110 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2007 | 458 | 0.110 |
Why?
|
| Molecular Structure | 2 | 2007 | 560 | 0.110 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2013 | 20 | 0.100 |
Why?
|
| Mucin-1 | 1 | 2012 | 11 | 0.100 |
Why?
|
| Animals | 6 | 2021 | 16695 | 0.100 |
Why?
|
| Acetylation | 1 | 2012 | 108 | 0.090 |
Why?
|
| Mice | 3 | 2018 | 6490 | 0.090 |
Why?
|
| Lectins | 1 | 2011 | 19 | 0.090 |
Why?
|
| Lectins, C-Type | 1 | 2011 | 37 | 0.090 |
Why?
|
| Galectins | 1 | 2011 | 29 | 0.090 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2011 | 66 | 0.090 |
Why?
|
| Computational Biology | 1 | 2012 | 324 | 0.080 |
Why?
|
| Photolysis | 1 | 2009 | 25 | 0.080 |
Why?
|
| Middle Aged | 2 | 2022 | 11819 | 0.080 |
Why?
|
| Urea | 1 | 2009 | 44 | 0.080 |
Why?
|
| Thermodynamics | 1 | 2009 | 226 | 0.070 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 1559 | 0.070 |
Why?
|
| Esters | 1 | 2007 | 25 | 0.070 |
Why?
|
| Fluorenes | 1 | 2007 | 26 | 0.060 |
Why?
|
| Carbohydrate Sequence | 1 | 2006 | 20 | 0.060 |
Why?
|
| Erythropoietin | 1 | 2006 | 36 | 0.060 |
Why?
|
| Asparagine | 1 | 2005 | 9 | 0.060 |
Why?
|
| Disaccharides | 1 | 2005 | 12 | 0.060 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2006 | 140 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2005 | 385 | 0.050 |
Why?
|
| Serologic Tests | 1 | 2022 | 45 | 0.050 |
Why?
|
| Bolivia | 1 | 2021 | 9 | 0.050 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2021 | 14 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 358 | 0.040 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2019 | 102 | 0.040 |
Why?
|
| Middle East | 1 | 2018 | 21 | 0.040 |
Why?
|
| Macaca mulatta | 1 | 2019 | 139 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2018 | 95 | 0.040 |
Why?
|
| Biological Specimen Banks | 1 | 2018 | 28 | 0.040 |
Why?
|
| Galactosyltransferases | 1 | 2017 | 6 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 1574 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2021 | 1586 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2018 | 487 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2017 | 167 | 0.030 |
Why?
|
| Isomerism | 1 | 2016 | 65 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2017 | 181 | 0.030 |
Why?
|
| Ions | 1 | 2016 | 71 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2017 | 276 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2019 | 875 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 1416 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2017 | 1010 | 0.030 |
Why?
|
| Adult | 2 | 2021 | 13458 | 0.030 |
Why?
|
| Child | 1 | 2021 | 3381 | 0.030 |
Why?
|
| Epitope Mapping | 1 | 2012 | 31 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2012 | 41 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2012 | 206 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2012 | 301 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 1188 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2009 | 59 | 0.020 |
Why?
|
| Protein Binding | 1 | 2012 | 1076 | 0.020 |
Why?
|
| Kinetics | 1 | 2009 | 698 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 4936 | 0.020 |
Why?
|
| Adolescent | 1 | 2018 | 5950 | 0.020 |
Why?
|
| Female | 2 | 2018 | 24018 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 1679 | 0.010 |
Why?
|
| Male | 1 | 2018 | 22779 | 0.010 |
Why?
|